Chronic Kidney Disease Trial, Recruiting NCT07485075 Sponsor: Steno Diabetes Center Copenhagen Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07485075
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Type 2 diabetes
  • People who are between 18 and 74 years old
  • People with a body mass index (a measure of body weight relative to height) below 35
  • People whose kidneys are working at a reduced but specific level — with an eGFR (a kidney function score) between 30 and 59, and a urine test showing a certain level of protein (UACR above 30 mg/g) (confirm with trial site)
  • People whose medications have remained unchanged for at least 3 months
  • People who are able to read and understand Danish

Who may not be able to join:

  • People who have Type 1 diabetes or any other type of diabetes besides Type 2
  • People who currently follow a vegan diet
  • People who have an active cancer diagnosis
  • People who have short bowel syndrome or coeliac disease (conditions that affect how the gut absorbs food)
  • People who currently take sodium chloride (salt) tablets
  • People in the intervention group who do not have access to a digital platform, such as a smartphone, tablet, or computer (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Steno Diabetes Center Copenhagen
Registry
ClinicalTrials.gov
Start date
20 March 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change in sodium excretion between measurements at baseline and 6 months follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov